Long-awaited treatment for hepatitis C virus decompensated cirrhosis

J Gastroenterol. 2019 Mar;54(3):299-300. doi: 10.1007/s00535-018-01538-6. Epub 2019 Jan 1.

Author

Kiminori Kimura¹

Affiliation

¹ Department of Hepatology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan. kkimura@cick.jp.

PMID: 30599052
DOI: 10.1007/s00535-018-01538-6

No abstract available

Publication types

Editorial
Comment

MeSH terms

Carbamates
Hepacivirus
Hepatitis C*
Heterocyclic Compounds, 4 or More Rings
Humans
Japan
Liver Cirrhosis*
Ribavirin
Sofosbuvir

Substances

Carbamates
Heterocyclic Compounds, 4 or More Rings
Ribavirin
velpatasvir
Sofosbuvir